The United States Peripheral Artery Disease Interventions Landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook

Angioplasty Procedures Continue to Grow in Volumes, while New Technologies Like Atherectomy Are in High Growth Rates in the Usa

The United States Peripheral Artery Disease (PAD) Interventional Landscape report is the first ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary research conducted with performing physicians in Interventional Radiology, Interventional Cardiology and Vascular Surgery departments from Academic Hospitals, Community Hospitals, Office Based Labs (OBL) and Private Hospitals in the USA. 

The report has insights on peripheral interventional procedures including lower extremity and upper extremity procedures and covers interventional devices such as peripheral stents, peripheral angioplasty balloons, atherectomy devices, carotid artery stents, and embolic protection devices. The report covers procedure trends by facility type, stages of disease, artery location, performing departments, route of access used for the intervention and by patient discharge.

Reimbursement coverage for peripheral stenting and angioplasty does not have much difference; however, there is low uptake of carotid artery stenting due to stringent conditions for reimbursement.

Physician’s brand perception and their rank of medical device companies based on 15 KPI’s such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of device, cost effectiveness among others effecting brand usage have been covered.

Endovascular interventions in lower extremity are considered as second line of treatment, Transcarotid Artery Revascularization TCAR has potential to replace carotid endarterectomy. Development of early detection and optimal referral pathway are expected to increase procedure volumes for peripheral vascular interventions. Availability of new angioplasty techniques such as shockwave technology will have a positive impact on the procedure trends.

The competitive updates covered in this report include the recent approval of IN. PACT 018 a low-profile drug coated balloon platform from Medtronic, the product is indicated for the treatment of peripheral arterial disease in superficial femoral and popliteal arteries; and the acquisition of Straub Medical AG - a developer of atherectomy and thrombectomy devices for PAD and venous diseases, by BD in 2020.

This report will help peripheral artery devices (PAD) interventional devices companies understand the peripheral artery intervention landscape, procedural and technology trends, the brand perception and competitive intelligence in the USA. The report is a great resource to plan your market strategy to capitalize on upcoming trends and potential disruptors in the PAD interventional devices market. The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model. Contact us for further details regarding the exclusive data and insights in the report or for an exploratory analyst walk through of the report. 

Why Buy This Report

• First-ever syndicated report with robust insights from Interventional Cardiologists, Vascular Surgeons, and Interventional Radiologists 
• Helps in understanding the current peripheral artery disease interventional landscape in the USA
• Includes 100+ slide MS PowerPoint report and a MS Excel based 5-year market forecast model 
• Valuable insights from  demand side of the market
• Keep up with the latest market trends and novel technologies 
• Identify key players, local players and emerging players in the market